Virbac SA
PAR:VIRP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Virbac SA
PAR:VIRP
|
FR |
|
E
|
EOG Resources Inc
F:EO5
|
US |
|
United Internet AG
XETRA:UTDI
|
DE |
|
A
|
Asahi Kasei Corp
SWB:ASAA
|
JP |
|
Indian Railway Catering and Tourism Corporation Ltd
NSE:IRCTC
|
IN |
|
A
|
Analog Devices Inc
DUS:ANL
|
US |
|
L
|
Ladder Capital Corp
F:LD1A
|
US |
|
B
|
Buckle Inc
F:BK2
|
US |
|
Greenfirst Forest Products Inc
TSX:GFP
|
CA |
|
O
|
OKA Corporation Bhd
KLSE:OKA
|
MY |
|
Focus Graphite Inc
XTSX:FMS
|
CA |
|
D
|
Denso Corp
XMUN:DNO
|
JP |
|
E
|
Eisen und Huettenwerke AG
F:EIS
|
DE |
|
d'Amico International Shipping SA
MIL:DIS
|
LU |
|
DPM Metals Inc
F:DPU0
|
CA |
Bankruptcy Probability
Virbac SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virbac SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Virbac SA
PAR:VIRP
|
2.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
622.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
355B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
338.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
317B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
160.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virbac SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virbac SA has total debt of 253.4m EUR. This includes both short-term (13.6m EUR) and long-term (239.7m EUR) debt.
You can find a full breakdown on its Balance Sheet.